Tag: #lungcancer

Pfizer’s Phase 3 Lung Cancer Drug Misses Overall Survival Goal; Stronger Trend in Second‑Line Patients

Pfizer's Phase 3 lung cancer trial of sigvotatug vedotin missed its overall survival goal; company sees a stronger trend in second‑line patients.

$PFE, #pfizer, #oncology, #lungcancer, #clinicaltrials

UK to spend nearly £30m to expand AI diagnostics in the NHS; £20m to roll out chest X‑ray tools to trusts by 2029

UK to invest almost £30m to expand AI-assisted diagnostics in the NHS, including £20m to roll out AI chest X-ray tools to all English trusts by 2029.

#nhs, #ai, #healthcare, #lungcancer

Interim phase 3: Sacituzumab tirumotecan plus pembrolizumab improves PFS in PD-L1–positive advanced NSCLC

Interim phase 3 data: adding sacituzumab tirumotecan to pembrolizumab improved progression-free survival versus pembrolizumab alone in PD‑L1+ advanced NSCLC; OS immature, toxicity higher.

$MRK, #lungcancer, #pembrolizumab, #sacituzumabtirumotecan, #clinicaltrials

NHS England screening programme detects 10,678 lung cancers, majority found at early stages

NHS England’s lung screening programme has detected 10,678 cancers, with more than three-quarters found at stage 1 or 2 after community mobile scans.

#lungcancer, #nhs, #screening, #publichealth